Monte, C.d.; MartÃ, C.; RodrÃguez, E.; Moreno-Palacios, E.; FrÃas, L.; Meléndez, M.; Loayza, A.; Yébenes, L.; Sánchez-Méndez, J.I.
Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer. Curr. Oncol. 2026, 33, 99.
https://doi.org/10.3390/curroncol33020099
AMA Style
Monte Cd, Martà C, RodrÃguez E, Moreno-Palacios E, FrÃas L, Meléndez M, Loayza A, Yébenes L, Sánchez-Méndez JI.
Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer. Current Oncology. 2026; 33(2):99.
https://doi.org/10.3390/curroncol33020099
Chicago/Turabian Style
Monte, Celia del, Covadonga MartÃ, Elena RodrÃguez, Elisa Moreno-Palacios, Laura FrÃas, Marcos Meléndez, Adolfo Loayza, Laura Yébenes, and José Ignacio Sánchez-Méndez.
2026. "Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer" Current Oncology 33, no. 2: 99.
https://doi.org/10.3390/curroncol33020099
APA Style
Monte, C. d., MartÃ, C., RodrÃguez, E., Moreno-Palacios, E., FrÃas, L., Meléndez, M., Loayza, A., Yébenes, L., & Sánchez-Méndez, J. I.
(2026). Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer. Current Oncology, 33(2), 99.
https://doi.org/10.3390/curroncol33020099